MedPath

Double Blind Controlled Trial of an Extensively Hydrolyzed Formula With a Probiotic vs. an Extensively Hydrolyzed Formula Without a Probiotic

Not Applicable
Completed
Conditions
Allergy
Interventions
Other: Extensively Hydrolyzed Formula with a Probiotic
Other: Extensively Hydrolyzed Formula without a Probiotic
Registration Number
NCT01181297
Lead Sponsor
Mead Johnson Nutrition
Brief Summary

The purpose of this study is to confirm the hypoallergenicity of an extensively hydrolyzed formula with an added probiotic in children with documented milk allergy.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria
  • ≤14 years of age
  • Essentially asymptomatic for a minimum of 7 days pre-challenge.
  • Successful previous consumption of Extensively Hydrolyzed Formula within 1 week of study enrollment
  • Medically documented allergy to cow's milk
Exclusion Criteria
  • Presence of underlying systemic disease or other illness
  • Used Beta-blockers within 12-24 hours of challenges
  • Use of short-acting antihistamines within 3 days
  • Use of medium-acting antihistamines within 7 days
  • Use of long-acting antihistamines within 6 weeks
  • Use of oral steroid medication within 3 weeks

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Extensively Hydrolyzed Formula with a ProbioticExtensively Hydrolyzed Formula with a ProbioticExtensively Hydrolyzed Formula with a Probiotic
Extensively Hydrolyzed Formula without a ProbioticExtensively Hydrolyzed Formula without a Probiotic-
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Dept. of Paediatrics, Azienda Ospedaliera di Padova

🇮🇹

Padova, Veneto, Italy

Wilhelmina Children's Hospital

🇳🇱

Utrecht, Netherlands

© Copyright 2025. All Rights Reserved by MedPath